Medicina
Fachbereich
Hamad Medical Corporation
Doha, QatarPublikationen in Zusammenarbeit mit Forschern von Hamad Medical Corporation (9)
2024
2023
2022
-
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Frontiers in Oncology, Vol. 12
-
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis
JAMA Dermatology, Vol. 158, Núm. 5, pp. 561-572
2021
-
Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram
Mayo Clinic Proceedings, Vol. 96, Núm. 8, pp. 2081-2094
2020
-
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma
Leukemia, Vol. 34, Núm. 11, pp. 3007-3018
-
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination
Leukemia, Vol. 34, Núm. 2, pp. 589-603
2019
-
Registro Nacional de Fracturas de Cadera (RNFC): resultados del primer año y comparación con otros registros y estudios multicéntricos españoles
Revista espanola de salud publica, Vol. 93
-
Spanish National Hip Fracture Registry (RNFC): analysis of its first annual report and international comparison with other established registries
Osteoporosis International